Aduro Biotech Inc (ADRO)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-08-01 | 2023-08-01 | S Sale |
Chief Scientific Officer Officer |
1,168
-5.7%
39.03USD 45,586 |
1,168 -5.7% | 39.03 | USD 45,586 | |
| 2023-05-31 | 2023-05-30 | PS Planned sale | Non-Executive Director |
1,155
-4.7%
23.30USD 26,912 |
1,155 -4.7% | 23.30 | USD 26,912 | |
| 2023-04-26 | 2023-04-24 | PS Planned sale |
President, CEO Executive Director |
23,800
-7.3%
21.58USD 513,528 |
23,800 -7.3% | 21.58 | USD 513,528 | |
| 2023-04-19 | 2023-04-17 | S Sale | Non-Executive Director |
295,808
-40.0%
20.75USD 6,138,223 |
295,808 -40.0% | 20.75 | USD 6,138,223 | |
| 2023-04-04 | 2023-04-04 | PS Planned sale | Non-Executive Director |
924
-42.0%
23.01USD 21,261 |
924 -42.0% | 23.01 | USD 21,261 | |
| 2023-04-05 | 2023-04-03 | PS Planned sale |
Chief Scientific Officer Officer |
5,000
-22.7%
23.34USD 116,718 |
5,000 -22.7% | 23.34 | USD 116,718 | |
| 2023-03-03 | 2023-03-01 | S Sale | Non-Executive Director |
36,751
-14.8%
22.75USD 836,085 |
36,751 -14.8% | 22.75 | USD 836,085 | |
| 2023-03-03 | 2023-03-01 | S Sale | Non-Executive Director |
123,249
-14.6%
22.75USD 2,803,915 |
123,249 -14.6% | 22.75 | USD 2,803,915 | |
| 2023-03-03 | 2023-03-01 | S Sale | Non-Executive Director |
240,000
-10.2%
22.75USD 5,460,000 |
240,000 -10.2% | 22.75 | USD 5,460,000 | |
| 2023-02-15 | 2023-02-10 | S Sale |
Chief Scientific Officer Officer |
2,392
-10.9%
23.75USD 56,806 |
2,392 -10.9% | 23.75 | USD 56,806 | |
| 2023-02-15 | 2023-02-10 | S Sale |
Chief Financial Officer Officer |
857
-2.2%
23.75USD 20,352 |
857 -2.2% | 23.75 | USD 20,352 | |
| 2023-02-15 | 2023-02-10 | S Sale |
Chief Operating Officer Officer |
3,700
-2.4%
23.75USD 87,869 |
3,700 -2.4% | 23.75 | USD 87,869 | |
| 2023-02-15 | 2023-02-10 | S Sale |
President, CEO Executive Director |
8,097
-2.6%
23.75USD 192,292 |
8,097 -2.6% | 23.75 | USD 192,292 | |
| 2023-02-02 | 2023-01-31 | S Sale |
Chief Scientific Officer Officer |
3,244
-17.7%
24.68USD 80,069 |
3,244 -17.7% | 24.68 | USD 80,069 | |
| 2023-02-02 | 2023-01-31 | S Sale |
Chief Operating Officer Officer |
4,566
-3.0%
24.68USD 112,700 |
4,566 -3.0% | 24.68 | USD 112,700 | |
| 2023-02-02 | 2023-01-31 | S Sale |
Chief Financial Officer Officer |
2,891
-7.2%
24.68USD 71,357 |
2,891 -7.2% | 24.68 | USD 71,357 | |
| 2023-02-01 | 2023-01-31 | S Sale |
President, CEO Executive Director |
7,688
-2.6%
24.68USD 189,757 |
7,688 -2.6% | 24.68 | USD 189,757 | |
| 2023-02-01 | 2023-01-30 | PS Planned sale |
President, CEO Executive Director |
25,000
-8.4%
24.54USD 613,613 |
25,000 -8.4% | 24.54 | USD 613,613 | |
| 2023-01-04 | 2023-01-03 | PS Planned sale |
Chief Scientific Officer Officer |
10,000
-50.0%
25.82USD 258,183 |
10,000 -50.0% | 25.82 | USD 258,183 | |
| 2022-12-15 | 2022-12-13 | PS Planned sale |
Chief Operating Officer Officer |
10,000
-6.5%
25.00USD 250,005 |
10,000 -6.5% | 25.00 | USD 250,005 | |
| 2022-12-02 | 2022-12-01 | PS Planned sale |
President, CEO Executive Director |
30,000
-11.0%
22.31USD 669,351 |
30,000 -11.0% | 22.31 | USD 669,351 | |
| 2022-12-02 | 2022-12-01 | S Sale |
Chief Financial Officer Officer |
5,770
-14.9%
22.29USD 128,602 |
5,770 -14.9% | 22.29 | USD 128,602 | |
| 2022-11-09 | 2022-11-07 | PS Planned sale |
Chief Operating Officer Officer |
10,000
-6.5%
22.16USD 221,642 |
10,000 -6.5% | 22.16 | USD 221,642 | |
| 2022-10-11 | 2022-10-06 | S Sale |
Chief Operating Officer Officer |
7,360
-4.9%
19.69USD 144,933 |
7,360 -4.9% | 19.69 | USD 144,933 | |
| 2022-10-11 | 2022-10-06 | S Sale |
Chief Scientific Officer Officer |
3,557
-22.2%
19.69USD 70,044 |
3,557 -22.2% | 19.69 | USD 70,044 | |
| 2022-09-06 | 2022-09-02 | B Purchase | Non-Executive Director |
300
+3.1%
21.20USD 6,360 |
300 +3.1% | 21.20 | USD 6,360 | |
| 2022-09-06 | 2022-09-02 | B Purchase | Non-Executive Director |
9,700
+inf%
21.22USD 205,834 |
9,700 +inf% | 21.22 | USD 205,834 | |
| 2022-08-05 | 2022-08-04 | PS Planned sale |
Chief Scientific Officer Officer |
5,000
-45.9%
20.00USD 100,000 |
5,000 -45.9% | 20.00 | USD 100,000 | |
| 2022-07-13 | 2022-07-11 | PS Planned sale |
Chief Scientific Officer Officer |
5,000
-45.9%
18.09USD 90,468 |
5,000 -45.9% | 18.09 | USD 90,468 | |
| 2022-06-01 | 2022-05-27 | B Purchase | Non-Executive Director |
570,000
+12.4%
14.00USD 7,980,000 |
570,000 +12.4% | 14.00 | USD 7,980,000 | |
| 2022-05-27 | 2022-05-25 | B Purchase |
President, CEO Executive Director |
5,000
+2.5%
13.03USD 65,148 |
5,000 +2.5% | 13.03 | USD 65,148 | |
| 2022-04-13 | 2022-04-11 | PS Planned sale |
Chief Scientific Officer Officer |
5,000
-45.9%
15.36USD 76,812 |
5,000 -45.9% | 15.36 | USD 76,812 | |
| 2022-02-23 | 2022-02-18 | PS Planned sale |
Chief Scientific Officer Officer |
2,500
-29.8%
13.00USD 32,500 |
2,500 -29.8% | 13.00 | USD 32,500 | |
| 2022-02-14 | 2022-02-11 | S Sale |
Chief Financial Officer Officer |
895
-3.9%
12.74USD 11,403 |
895 -3.9% | 12.74 | USD 11,403 | |
| 2022-02-14 | 2022-02-11 | S Sale |
Chief Medical Officer Officer |
2,391
-23.3%
12.74USD 30,464 |
2,391 -23.3% | 12.74 | USD 30,464 | |
| 2022-02-14 | 2022-02-11 | S Sale |
Chief Scientific Officer Officer |
2,498
-22.9%
12.74USD 31,827 |
2,498 -22.9% | 12.74 | USD 31,827 | |
| 2022-02-14 | 2022-02-11 | S Sale |
Chief Operating Officer Officer |
3,735
-2.6%
12.74USD 47,587 |
3,735 -2.6% | 12.74 | USD 47,587 | |
| 2022-02-11 | 2022-02-10 | PS Planned sale |
Chief Scientific Officer Officer |
2,500
-37.9%
13.31USD 33,275 |
2,500 -37.9% | 13.31 | USD 33,275 | |
| 2022-01-05 | 2022-01-03 | PS Planned sale |
Versant Venture Capital VII, L.P. Large shareholder |
92,000
-14.3%
16.00USD 1,472,018 |
92,000 -14.3% | 16.00 | USD 1,472,018 | |
| 2022-01-05 | 2022-01-03 | PS Planned sale |
Versant Venture Capital VII, L.P. Large shareholder |
308,000
-14.2%
16.00USD 4,928,062 |
308,000 -14.2% | 16.00 | USD 4,928,062 | |
| 2022-01-05 | 2022-01-03 | PS Planned sale |
Versant Venture Capital VII, L.P. Large shareholder |
600,000
-14.2%
16.00USD 9,600,120 |
600,000 -14.2% | 16.00 | USD 9,600,120 | |
| 2022-01-05 | 2022-01-03 | PS Planned sale | Non-Executive Director Large shareholder |
92,000
-14.3%
16.00USD 1,472,018 |
92,000 -14.3% | 16.00 | USD 1,472,018 | |
| 2022-01-05 | 2022-01-03 | PS Planned sale | Non-Executive Director Large shareholder |
308,000
-14.2%
16.00USD 4,928,062 |
308,000 -14.2% | 16.00 | USD 4,928,062 | |
| 2022-01-05 | 2022-01-03 | PS Planned sale | Non-Executive Director Large shareholder |
600,000
-14.2%
16.00USD 9,600,120 |
600,000 -14.2% | 16.00 | USD 9,600,120 | |
| 2021-11-17 | 2021-11-15 | B Purchase | Non-Executive Director |
1,215,000
+36.0%
14.00USD 17,010,000 |
1,215,000 +36.0% | 14.00 | USD 17,010,000 | |
| 2021-11-12 | 2021-11-10 | PS Planned sale |
Chief Operating Officer Officer |
6,230
-4.4%
15.48USD 96,440 |
6,230 -4.4% | 15.48 | USD 96,440 | |
| 2021-11-12 | 2021-11-09 | PS Planned sale |
Chief Scientific Officer Officer |
5,000
-55.0%
13.53USD 67,660 |
5,000 -55.0% | 13.53 | USD 67,660 | |
| 2021-11-09 | 2021-11-08 | PS Planned sale |
Chief Operating Officer Officer |
13,770
-8.9%
15.17USD 208,938 |
13,770 -8.9% | 15.17 | USD 208,938 | |
| 2021-11-09 | 2021-11-05 | PS Planned sale |
Chief Operating Officer Officer |
5,000
-3.1%
14.00USD 70,000 |
5,000 -3.1% | 14.00 | USD 70,000 | |
| 2021-11-09 | 2021-11-05 | PS Planned sale |
Chief Operating Officer Officer |
15,000
-8.6%
14.00USD 210,000 |
15,000 -8.6% | 14.00 | USD 210,000 | |
| 2021-06-17 | 2021-06-16 | PS Planned sale |
Chief Medical Officer Officer |
20,000
-100.0%
16.35USD 326,968 |
20,000 -100.0% | 16.35 | USD 326,968 | |
| 2021-05-18 | 2021-05-14 | B Purchase |
President, CEO Executive Director |
1,000
+1.3%
14.44USD 14,440 |
1,000 +1.3% | 14.44 | USD 14,440 | |
| 2020-12-10 | 2020-12-09 | B Purchase |
President, CEO Executive Director |
2,000
+3.6%
13.08USD 26,150 |
2,000 +3.6% | 13.08 | USD 26,150 | |
| 2020-12-10 | 2020-12-08 | B Purchase |
President, CEO Executive Director |
2,000
+3.8%
13.24USD 26,483 |
2,000 +3.8% | 13.24 | USD 26,483 | |
| 2020-11-23 | 2020-11-23 | B Purchase |
President, CEO Executive Director |
929
+1.8%
13.67USD 12,699 |
929 +1.8% | 13.67 | USD 12,699 | |
| 2020-11-23 | 2020-11-20 | B Purchase |
President, CEO Executive Director |
571
+1.1%
13.69USD 7,817 |
571 +1.1% | 13.69 | USD 7,817 | |
| 2020-11-23 | 2020-11-19 | B Purchase |
President, CEO Executive Director |
500
+1.0%
13.50USD 6,750 |
500 +1.0% | 13.50 | USD 6,750 | |
| 2020-11-13 | 2020-11-11 | B Purchase |
President, CEO Executive Director |
2,500
+5.2%
13.75USD 34,375 |
2,500 +5.2% | 13.75 | USD 34,375 | |
| 2020-11-13 | 2020-11-10 | B Purchase |
President, CEO Executive Director |
2,000
+4.3%
13.86USD 27,720 |
2,000 +4.3% | 13.86 | USD 27,720 | |
| 2020-09-17 | 2020-09-15 | S Sale |
SVP, GC and Secretary Officer |
2,396
-5.8%
2.39USD 5,731 |
2,396 -5.8% | 2.39 | USD 5,731 | |
| 2020-09-17 | 2020-09-15 | S Sale |
Chief Legal Officer Officer |
12,369
-9.2%
2.39USD 29,585 |
12,369 -9.2% | 2.39 | USD 29,585 | |
| 2020-09-17 | 2020-09-15 | S Sale |
President and CEO Executive Director |
32,481
-10.4%
2.39USD 77,691 |
32,481 -10.4% | 2.39 | USD 77,691 | |
| 2020-08-11 | 2020-08-07 | S Sale |
Chief Medical Officer Officer |
3,538
-29.5%
2.55USD 9,036 |
3,538 -29.5% | 2.55 | USD 9,036 | |
| 2020-08-11 | 2020-08-07 | S Sale |
SVP, GC and Secretary Officer |
7,951
-16.2%
2.55USD 20,308 |
7,951 -16.2% | 2.55 | USD 20,308 | |
| 2020-08-11 | 2020-08-07 | S Sale |
Chief Legal Officer Officer |
7,951
-5.6%
2.55USD 20,308 |
7,951 -5.6% | 2.55 | USD 20,308 | |
| 2020-02-26 | 2020-02-25 | S Sale |
Chief Scientific Officer Officer |
6,823
-1.5%
3.51USD 23,954 |
6,823 -1.5% | 3.51 | USD 23,954 | |
| 2020-01-06 | 2020-01-03 | S Sale |
Chief Scientific Officer |
73,311
-14.1%
1.19USD 87,108 |
73,311 -14.1% | 1.19 | USD 87,108 | |
| 2019-12-16 | 2019-12-12 | S Sale |
Ferber Celeste SVP, GC and Secretary Officer |
408
-1.5%
1.16USD 475 |
408 -1.5% | 1.16 | USD 475 | |
| 2019-12-16 | 2019-12-12 | S Sale |
van Elsas Andrea Chief Scientific Officer Officer |
2,192
-0.4%
1.16USD 2,550 |
2,192 -0.4% | 1.16 | USD 2,550 | |
| 2019-12-16 | 2019-12-12 | S Sale |
ISAACS STEPHEN T President and CEO Executive Director |
5,897
-2.0%
1.16USD 6,860 |
5,897 -2.0% | 1.16 | USD 6,860 | |
| 2019-12-16 | 2019-12-12 | PS Planned sale |
Templeman Blaine Chief Legal Officer Officer |
1,264
-1.1%
1.16USD 1,470 |
1,264 -1.1% | 1.16 | USD 1,470 | |
| 2019-09-17 | 2019-09-13 | S Sale |
Chief Scientific Officer |
634
-0.1%
1.31USD 828 |
634 -0.1% | 1.31 | USD 828 | |
| 2019-09-17 | 2019-09-13 | S Sale |
Chief Scientific Officer |
17,959
-3.3%
1.31USD 23,451 |
17,959 -3.3% | 1.31 | USD 23,451 | |
| 2019-09-17 | 2019-09-13 | S Sale |
SVP, GC and Secretary |
1,102
-3.9%
1.31USD 1,439 |
1,102 -3.9% | 1.31 | USD 1,439 | |
| 2019-09-17 | 2019-09-13 | S Sale |
SVP, GC and Secretary |
1,392
-4.7%
1.31USD 1,818 |
1,392 -4.7% | 1.31 | USD 1,818 |